Informações:
Falhas:
ID
32830
Descrição
Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007); ODM derived from: https://clinicaltrials.gov/show/NCT00806585
Link
https://clinicaltrials.gov/show/NCT00806585
Palavras-chave
Versões (1)
- 16/11/2018 16/11/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
16 de novembro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Type 2 Diabetes Mellitus NCT00806585
Eligibility Type 2 Diabetes Mellitus NCT00806585
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT00806585
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Age
Item
must be 18 to 75 years of age
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | Hemoglobin A1c measurement
Item
type 2 diabetes mellitus (glycohemoglobin [a1chba1c]: 7 to 10%)
boolean
C0011860 (UMLS CUI [1])
C0474680 (UMLS CUI [2])
C0474680 (UMLS CUI [2])
Hypertensive disease | Diastolic blood pressure | Systolic Pressure
Item
hypertension: diastolic blood pressure (dbp; 85 to 99 mm hg) and systolic blood pressure (sbp; 120 to 159 mm hg)
boolean
C0020538 (UMLS CUI [1])
C0428883 (UMLS CUI [2])
C0871470 (UMLS CUI [3])
C0428883 (UMLS CUI [2])
C0871470 (UMLS CUI [3])
Low density lipoprotein cholesterol measurement
Item
ldl-c < 140 mg/dl
boolean
C0202117 (UMLS CUI [1])
Angiotensin-Converting Enzyme Inhibitors Stable | Angiotensin II receptor antagonist Stable
Item
on stable treatment with an angiotensin-converting enzyme inhibitor (acei) or angiotensin receptor blocker (arb)
boolean
C0003015 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0521942 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0205360 (UMLS CUI [1,2])
C0521942 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
Diabetes Mellitus, Insulin-Dependent
Item
history of type i diabetes mellitus or ketoacidosis
boolean
C0011854 (UMLS CUI [1])
Antihypertensive Agents Quantity
Item
patients taking 3 or more blood pressure lowering medications
boolean
C0003364 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
Chronic heart failure Severe
Item
have severe chronic heart failure
boolean
C0264716 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Cardiac Arrhythmia | Myocardial Infarction | Cerebrovascular accident | Angina, Unstable | Vascular Disease Decompensated
Item
history of certain diseases or conditions such as cardiac arrhythmias, heart attack, stroke, unstable angina, or decompensated vascular disease
boolean
C0003811 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
C0038454 (UMLS CUI [3])
C0002965 (UMLS CUI [4])
C0042373 (UMLS CUI [5,1])
C0205434 (UMLS CUI [5,2])
C0027051 (UMLS CUI [2])
C0038454 (UMLS CUI [3])
C0002965 (UMLS CUI [4])
C0042373 (UMLS CUI [5,1])
C0205434 (UMLS CUI [5,2])
Malignant Neoplasms
Item
history of cancer within the last 5 years
boolean
C0006826 (UMLS CUI [1])
HIV Seropositivity
Item
human immunodeficiency virus (hiv) positive
boolean
C0019699 (UMLS CUI [1])
Investigational New Drugs
Item
have received treatment with any investigational drugs within the past 30 days
boolean
C0013230 (UMLS CUI [1])
Substance Use Disorders
Item
history of alcohol or drug abuse within the past 3 years
boolean
C0038586 (UMLS CUI [1])
Body mass index
Item
body mass index ( bmi) >= 41 kg/m2
boolean
C1305855 (UMLS CUI [1])